You are here

Our science / Clinical Trials / Find a Trial / NCT00159692

Amlodipine Diabetic Hypertension Efficacy Response Trial

Back to Search Print Save as PDF Bookmark Trial

NCT00159692

Last updated on February 23, 2019
Back to Search Print Save as PDF Bookmark Trial

FOR MORE INFORMATION
Study Location
Contact
1-800-718-1021
[email protected]
Related Links
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Hypertension
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
30-75 years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Documented evidence of Type 2 diabetes as defined by the ADA guidelines and documented
evidence of Hypertension (various SBP/DBP ranges).

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- A previous history or intolerance or hypersensitivity to calcium channel blockers,
ARBs or ACE inhibitors.

NCT00159692
Pfizer
Completed
Amlodipine Diabetic Hypertension Efficacy Response Trial

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.
Advanced Search

Based on your search, you may also be interested in

Pulmonary Arterial Hypertension
To Assess The Efficacy and Safety Of Oral Sildenafil in the Treatment of Pulmonary Arterial Hypertension.
NCT00430716
All Genders
18+
Years
Multiple Sites
Glaucoma, Ocular Hypertension
Evaluation Of Intraocular Pressure Lowering-Effect Of Xalacom In Patients With Poag Or Oh.
NCT00143208
All Genders
18+
Years
Multiple Sites
Glaucoma, Ocular Hypertension
Non-Interventional Study In Patients With Ocular Hypertension And Open Angle Glaucoma Treated With Xalatan And Xalacom
NCT01012245
All Genders
Pulmonary Arterial Hypertension, Pulmonary Hypertension
Safety And Efficacy Of Sildenafil In Children With Pulmonary Arterial Hypertension
NCT01642407
All Genders
1+
Years
Multiple Sites

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now